Comparing Different Oxygen Thresholds for Surfactant Administration During Nasal IPPV in Very Preterm Neonates With Respiratory Distress Syndrome: A Superiority RCT
Comparing Different Oxygen Thresholds for Surfactant Administration During Nasal IPPV in Very Preterm Neonates With Respiratory Distress Syndrome: A Superiority RCT
This multicenter randomized controlled trial investigates whether initiating pulmonary surfactant (PS) at a lower oxygen threshold (FiO₂ >0.25) during nasal intermittent positive pressure ventilation (NIPPV) for very preterm infants with respiratory distress syndrome (RDS) reduces noninvasive ventilation failure rates (primary outcome: intubation requirement), compared to the standard threshold (FiO₂ >0.3). By establishing the clinical superiority of early PS administration, this study aims to refine evidence-based guidelines for RDS management in preterm neonates.
Inclusion Criteria:
(1) Gestational Age: 26 weeks +0 day to 31 weeks+6days at birth (inclusive). (2) Clinical Diagnosis of NRDS: Symptoms: Tachypnea, grunting, and/or progressive respiratory distress. Imaging Findings: Chest X-ray showing at least one of: Ground-glass opacity, Air bronchograms, Diffuse "white lung" pattern, Lung Ultrasound (recommended).
(3) Admission to NICU within 3 hours of birth. Requirement for non-invasive nasal intermittent positive pressure ventilation (NIPPV) at enrollment.
(4) Signed informed consent obtained from parent(s) or legal guardian(s).
Exclusion Criteria:
Invasive mechanical ventilation during delivery or transport to NICU.
Structural upper airway abnormalities precluding non-invasive ventilation.
Confirmed diagnosis of major congenital malformations
Endotracheal intubation for indications unrelated to NRDS (e.g., surgery, sepsis management)
Initiation of non-invasive ventilation >3 hours post-birth.
Voluntary discharge or treatment withdrawal within 72 hours post-enrollment.
Parental/guardian refusal to Sign informed consent or Authorize surfactant administration
Incomplete clinical records or missing key outcome variables
-
shiyuan@hospital.cqmu.edu.cn0791-86224432